Alberto Calvi

17PUBLICATIONS
115CO-AUTHORS
Molecular medicineGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Memory and attentionMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 13, 2026
Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

|Jun 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

|Jan 12, 2026
Cognitive outcomes in multiple sclerosis are shaped by divergent functional connectivity trajectories.

Eloy Martinez-Heras, Elisabet Lopez-Soley, Chiara Cabras

|Sep 02, 2025
Diffusivity anisotropy signature of slowly expanding lesions predicts progression independent of relapse activity in multiple sclerosis.

Alberto Calvi, Francesc Vivó Pascual, Elisabeth Solana

|Dec 18, 2024
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial.

Floriana De Angelis, James R Cameron, Arman Eshaghi

Pageof 3

Frequent Collaborators

6 joint publications

Sara Llufriu

5 joint publications

Eloy Martinez-Heras

4 joint publications

Nevin John

4 joint publications

Elisabeth Solana